Your session is about to expire
← Back to Search
Clade C and Mosaic gp140 HIV bivalent vaccine for Healthy Subjects (MOSAICO Trial)
MOSAICO Trial Summary
This trial is testing a new HIV vaccine to see if it can prevent HIV-1 infection in cis-gender men and transgender individuals.
- Healthy Subjects
MOSAICO Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MOSAICO Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Would this be an appropriate treatment regimen for elderly patients?
"This study requires that potential participants be aged 18-60."
Are there any qualifications required to participate in this experiment?
"This international trial is looking for 3,900 individuals currently infected with HIV. In addition to being between 18-60 years old, participants must meet the following requirements: Be in good health based on medical history, physical examination, and vital sign measurement performed at screening, Be a cis-gender man having sex with cis-gender men and/or transgender individuals or transgender woman having sex with cis-gender men and/or transgender individuals or transgender man having sex with cis-gender men and/or transgender women or gender non-conforming individual having receptive or insertive anal and/or vaginal condom-less intercourse and who is considered by the"
Are there any spots left for volunteers in this clinical trial?
"The study in question, while not recruiting at this moment, was last edited on 10/25/2022. According to the data on clinicaltrials.gov, there are 1671 other trials that are actively seeking patients."
Share this study with friends
Copy Link
Messenger